Onco-Innovations Limited: Onco-Innovations' PKNP Technology Shown in Study to Demonstrate ...
VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding it ...
Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High ...
VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding ...
MedPage Today1 小时
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression Risk
Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
Healio8 小时
‘Tsunami of effort’ brings biologics to the forefront in giant cell arteritis, PMR
Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...
oncnursingnews8 小时
Becoming Familiar With Patients’ AEs is Essential, Says Expert
Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...
Knowridge14 小时
Common heartburn drugs may harm your kidney health
Proton pump inhibitors (PPIs) are widely used in the U.S. to treat heartburn, acid reflux, and gastroesophageal reflux ...